Human Infections with Borrelia miyamotoi,Japan

We confirmed infection of 2 patients with Borrelia miyamotoi in Japan by retrospective surveillance of Lyme disease patients and detection of B. miyamotoi DNA in serum samples. One patient also showed seroconversion for antibody against recombinant glycerophosphodiester phosphodiesterase of B. miyamotoi. Indigenous relapsing fever should be considered a health concern in Japan.     

Comparison of Lyme Disease in the United States and Europe

Lyme disease, or Lyme borreliosis, is the most common tickborne disease in the United States and Europe. In both locations, Ixodes species ticks transmit the Borrelia burgdorferi sensu lato bacteria species responsible for causing the infection. The diversity of Borrelia species that cause human infection is greater in Europe; the 2 B. burgdorferi s.l. species collectively responsible for most infections in Europe, B. afzelii and B. garinii, are not found in the United States, where most infections are caused by B. burgdorferi sensu stricto. Strain differences seem to explain some of the variation in the clinical manifestations of Lyme disease, which are both minor and substantive, between the United States and Europe. Future studies should attempt to delineate the specific virulence factors of the different species of B. burgdorferi s.l. responsible for these variations in clinical features.     

Prevalence of Borrelia miyamotoi in Ixodes Ticks in Europe and the United States

Borrelia miyamotoi, a relapsing fever-related spirochete transmitted by Ixodes ticks, has been recently shown to be a human pathogen. To characterize the prevalence of this organism in questing Ixodes ticks, we tested 2,754 ticks for a variety of tickborne pathogens by PCR and electrospray-ionization mass spectrometry. Ticks were collected from California, New York, Connecticut, Pennsylvania, and Indiana in the United States and from Germany and the Czech Republic in Europe from 2008 through 2012. In addition, an isolate from Japan was characterized. We found 3 distinct genotypes, 1 for North America, 1 for Europe, and 1 for Japan. We found B. miyamotoi infection in ticks in 16 of the 26 sites surveyed, with infection prevalence as high as 15.4%. These results show the widespread distribution of the pathogen, indicating an exposure risk to humans in areas where Ixodes ticks reside.     

黑龙江林区野鼠伯氏疏螺旋体核酸检测与序列分析

伯氏疏螺旋体共有13个基因种,国内分离到的菌株包括5个基因种[1-3],本研究对黑龙江地区啮齿动物中伯氏疏螺旋体进行分子流行病学调查和分析. 1.材料与方法: (1)样本采集、处理及DNA提取:2009-2011年4-7月从黑龙江林区采用夹夜法采集野鼠,每样点100×2夹次,按5m距离布放鼠夹,晚放晨收.现场鉴定鼠种后,将捕获的鼠放入鼠袋内,乙醚麻醉后,消毒,无菌取脾脏低温保存.采用天根生化科技(北京)有限公司血液/细胞/组织基因组DNA提取试剂盒提取脾脏DNA,-20℃贮存备用.     

广西乐业县林区莱姆病螺旋体分离及鉴定

为查明广西地区莱姆病的传播媒介以及是否存在B.valaisiana之外基因型莱姆病螺旋体,于2004年在乐业县林区进行了调查,现将调查结果报道如下.     

Borrelia miyamotoi in Human-Biting Ticks,United States, 2013–2019

During 2013–2019, Borrelia miyamotoi infection was detected in 19 US states. Infection rate was 0.5%–3.2%; of B. miyamotoi–positive ticks, 59.09% had concurrent infections. B. miyamotoi is homogeneous with 1 genotype from Ixodes scapularis ticks in northeastern and midwestern states and 1 from I. pacificus in western states.     

Humans infected with relapsing fever spirochete Borrelia miyamotoi, Russia

Borrelia miyamotoi is distantly related to B. burgdorferi and transmitted by the same hard-body tick species. We report 46 cases of B. miyamotoi infection in humans and compare the frequency and clinical manifestations of this infection with those caused by B. garinii and B. burgdorferi infection. All 46 patients lived in Russia and had influenza-like illness with fever as high as 39.5°C; relapsing febrile illness occurred in 5 (11%) and erythema migrans in 4 (9%). In Russia, the rate of B. miyamotoi infection in Ixodes persulcatus ticks was 1%-16%, similar to rates in I. ricinus ticks in western Europe and I. scapularis ticks in the United States. B. miyamotoi infection may cause relapsing fever and Lyme disease-like symptoms throughout the Holarctic region of the world because of the widespread prevalence of this pathogen in its ixodid tick vectors.     

Tick zoonoses in the southern part of Switzerland (Canton Ticino): occurrence of Borrelia burgdorferi sensu lato and Rickettsia sp.

The diversity and the distribution of tick species and their infection rates by the pathogenic micro-organism Borrelia burgdorferi sensu lato, the etiologic agent of Lyme borreliosis, and Rickettsia sp., were studied in Canton Ticino (the southern part of Switzerland). Ticks specimens collected from animals and humans were classified and analysed for the presence of both pathogens. In particular, PCR analysis was performed for the detection of Borrelia spirochetes in Ixodes ricinus and Ixodes hexagonus, and the hemolymph test was done on Rhipicephalus sanguineus for the detection of Rickettsia sp. PCR assays, performed on 424 of the 989 collected ticks, revealed a low rate of infection (around 2%) of both vectors I. ricinus and I. hexagonus by B. burgdorferi sensu lato. These results are in agreement with the modest number of Lyme borreliosis cases yearly recorded in Ticino. Further, through analysis of DNA sequences, the strains carried by the infected ticks were identified as belonging to the genomic group VS116. The widespread finding of the Mediterranean species Rhipicephalus sanguineus in different locations from July 1994 to October 1995 demonstrates its establishment in Ticino. Of the 210 specimens collected, 70 were analysed and one was infected by Rickettsia sp.     

浙江省在鼠形动物中检测到伯氏疏螺旋体

目的了解鼠形动物中自然感染伯氏疏螺旋体的状况。方法用巢式聚合酶链反应扩增鼠中的伯氏疏螺旋体5S--23SrRNA间隔区片段，对阳性产物进行测序。结果在浙江省金华市金东区捕获鼠形动物128只，在黄毛鼠、姬鼠、臭鼬鼯中共检测到阳性12份，阳性率分别为9．68％、14．28％和25．00％，并对其中2份进行测序分析，与伯氏疏螺旋体的法雷斯疏螺旋体相同，基因区间序列号分别为AB091447BvalaiOS115和DQ188933BvalaiQX13P25，相似率达100％。结论初步认为浙江省存在伯氏疏螺旋体病原。黄毛鼠、姬鼠、臭鼠句鼯可能为伯氏疏螺旋体的法雷斯疏螺旋体宿主，尚需进一步调查。     

中国六省蜱中莱姆病螺旋体分离与鉴定

目的 了解中国6省蜱中莱姆病螺旋体携带情况.方法 在6省各选取2个采样点捕蜱,采用病原分离培养和巢式PCR方法对蜱进行莱姆病螺旋体检测,通过基因测序确定分型.结果 6省共采集到2200余只蜱,约1000只蜱用于病原分离培养,从吉林省长白县全沟硬蜱标本中分离到13株螺旋体,从贵州省道真粒形硬蜱标本中分离到9株螺旋体.1255只蜱用于PCR检测,从6省的蜱标本中检测到莱姆病螺旋体特异片段,其中吉林省(长白县27.08%、通化县20.41%)、青海省(互助县25.06%、黄南县21.11%)和贵州省(道真县25.63%)蜱中莱姆病螺旋体阳性率较高,山西省(垣曲县4.72%、交城县3.64%)蜱中莱姆病螺旋体阳性率较低.通过序列同源性分析确定吉林、青海、甘肃和山西省蜱中莱姆病螺旋体基因型均为Borrelia garinii.贵州、湖南省的基因型均为Borrelia valaisiana.结论 6省蜱中均带有莱姆病螺旋体,且带菌率有差异;山西省蜱中存在Borrelia ganmi型莱姆病螺旋体,湖南省蜱中存在Borrelia valaisiana型莱姆病螺旋体.     

大兴安岭林区蜱和鼠中莱姆病螺旋体感染及其基因分型研究

目的 了解内蒙古大兴安岭林区蜱和鼠中伯氏疏螺旋体的感染及基因分型情况。方法 应用巢式PCR扩增蜱和鼠中伯氏疏螺旋体5S-23SrRNA间隔区片段，对阳性产物进行限制性片段长度多态性（RFLP）分析和单链构象多态性（SSCP）分析，RFLP分析显示特殊带型的样本测序分析。结果 检测全沟硬蜱1336只，293只阳性，阳性率为21．93％；森林革蜱144只，6只阳性，阳性率为4．17％；嗜群血蜱144只，未发现有伯氏疏螺旋体感染。检测鼠9种145只，感染伯氏疏螺旋体的4种5只，感染率为3．45％；其中检测8只棕背鼠平，2只阳性。RFLP分析及序列分析显示蜱中有B．garinii20047亚型、B．gariniiNT29亚型、B．afzelii基因型以及不同基因型或亚型伯氏疏螺旋体的混合感染；鼠感染的伯氏疏螺旋体包括B．garinii20047亚型和B．gariniiNT29亚型。SSCP分析结果显示带型多于36种。结论 大兴安岭林区蜱及鼠中均存在伯氏疏螺旋体的感染，其中全沟硬蜱的感染率较高；B．garinii型为主要基因型，且该地区伯氏疏螺旋体存在遗传多态性。单只蜱中存在同时感染不同基因型伯氏疏螺旋体的情况，人和宿主动物是否存在不同基因型伯氏疏螺旋体混合感染尚待进一步研究。全沟硬蜱和棕背鼾分别是该林区伯氏疏螺旋体的主要媒介和主要储存宿主。     

Evolution of Northeastern and Midwestern Borrelia burgdorferi, United States

The per capita incidence of human Lyme disease in the northeastern United States is more than twice that in the Midwest. However, the prevalence of Borrelia burgdorferi, the bacterium that causes Lyme disease, in the tick vector is nearly identical in the 2 regions. The disparity in human Lyme disease incidence may result from a disparity in the human invasiveness of the bacteria in the Northeast and Midwest caused by fundamentally different evolutionary histories. B. burgdorferi populations in the Northeast and Midwest are geographically isolated, enabling evolutionary divergence in human invasiveness. However, we found that B. burgdorferi populations in the Northeast and Midwest shared a recent common ancestor, which suggests that substantial evolutionary divergence in human invasiveness has not occurred. We propose that differences in either animal ecology or human behavior are the root cause of the differences in human incidence between the 2 regions.     

我国滇西北山区家犬莱姆病螺旋体基因的检测及序列分析

目的了解滇西北山区莱姆病伯氏疏螺旋体的自然感染及基因分型情况。方法以山区农村家犬作为指示动物,使用真空采血管抽取家犬全血,应用巢式PCR扩增犬血中伯氏疏螺旋体5S~23S rRNA间隔区片段,然后对阳性片段进行测序,并将所测序列与GenBank中注册的基因序列进行比较分析。结果共检测贡山、福贡2个县3个乡镇山村63只家犬血液,其中发现9只犬为阳性,阳性率14.29%。基因序列分析结果显示,当地犬感染的伯氏疏螺旋体为Borrelia garinii。结论首次证实云南省西北部山区家犬中存在莱姆病Borrelia garinii型伯氏疏螺旋体感染。     

黑龙江省东部边境口岸莱姆病生物媒介调查及病原分型研究

目的调查黑龙江省东部中俄边境口岸蜱的种类、分布、携带莱姆病螺旋体情况及病原基因型。方法捕蜱采用布旗法;蜱带莱姆病螺旋体率采用直接荧光法检查;病原体分离培养采用BSKⅡ培养基,对分离到的螺旋体用单克隆抗体(H_(5332)、H_(6831)、H_(9724))、SDS-PAGE蛋白图谱分析、PCR-RFLP分析以及基因测序等方法进行表型和基因分型研究。结果黑龙江省东部7个中俄边境口岸蜱的种类为1科3属4种,即硬蜱科硬蜱属全沟硬蜱,革蜱属森林革蜱,血蜱属嗜群血蜱和日本血蜱。不同生态环境中蜱的分布不同,各口岸优势蜱种不同。全沟硬蜱带莱姆病螺旋体率较高,平均为31.4%,森林革蜱和嗜群血蜱的带菌率较低,平均为2.2%和3.8%,日本血蜱中未检出阳性者。首次在中俄边境口岸——东宁、同江采集的全沟硬蜱中分离到伯氏疏螺旋体并鉴定为B.garinii基因型。结论黑龙江省东部边境口岸为莱姆病的自然疫源地。     

吉林省珲春地区蜱中伯氏疏螺旋体与斑点热群立克次体复合感染研究

目的了解吉林省珲春地区伯氏疏螺旋体与斑点热群立克次体的复合感染情况.方法运用PCR方法对吉林省珲春地区采集的蜱标本,进行伯氏疏螺旋体5S～23S rRNA间隔区基因与斑点热群立克次体外膜蛋白A（ompA）基因的检测.测序并用PHYLIP软件进行序列分析.结果全沟硬蜱中伯氏疏螺旋体感染率为36.0%,在全沟硬蜱中检测到了斑点热群立克次体的感染,其感染率为2 0%.二者的复合感染率为2.0%;森林革蜱中伯氏疏螺旋体感染率30.9%,斑点热群立克次体感染率29.1%,二者的复合感染率16.8%.伯氏疏螺旋体的序列分析显示吉林地区的伯氏疏螺旋体都属于B.garinii基因型,同源性较高.对斑点热阳性片段序列分析表明新测序列与斯洛伐克新发现的IRS3株和IRS4株核苷酸序列同源性为97%.结论吉林省珲春地区全沟硬蜱及森林革蜱中检测到伯氏疏螺旋体与斑点热群立克次体的感染,并检测到2种病原体的复合感染情况.     

Borrelia burgdorferi Sensu Stricto DNA in Field-Collected Haemaphysalis longicornis Ticks,Pennsylvania, United States

We collected questing Haemaphysalis longicornis ticks from southeastern counties of Pennsylvania, USA. Of 263 ticks tested by PCR for pathogens, 1 adult female was positive for Borrelia burgdorferi sensu stricto, yielding a 0.4% infection rate. Continued monitoring of this invasive tick is essential to determine its public health role.     

Pediatric Lyme Disease Biobank,United States, 2015–2020

In 2015, we founded Pedi Lyme Net, a pediatric Lyme disease research network comprising 8 emergency departments in the United States. Of 2,497 children evaluated at 1 of these sites for Lyme disease, 515 (20.6%) were infected. This network is a unique resource for evaluating new approaches for diagnosing Lyme disease in children.     

Estimating the Frequency of Lyme Disease Diagnoses,United States, 2010–2018

By using commercial insurance claims data, we estimated that Lyme disease was diagnosed and treated in ≈476,000 patients in the United States annually during 2010–2018. Our results underscore the need for accurate diagnosis and improved prevention.